|
Characteristics of the Eligible Trials (N = 76 Trials) |
|||||||||||
| Characteristics |
No. of Studies (Percent) |
JOT |
JBJS-Am |
JBJS-Br |
CORR |
Acta Orth. Scand |
Journal of Trauma |
Injury |
Foot and Ankle Internat. |
Journal Hand-Br. |
|
|
|
|||||||||||
| 1. |
First Author: |
||||||||||
| Surgeon: |
73/76 (96.0%) |
15/16 |
10/10 |
13/14 |
8/9 |
8/8 |
8/8 |
5/5 |
2/2 |
4/4 |
|
| Non-Surgeon: |
3/76 (4%) |
1/16 |
0/10 |
1/14 |
1/9 |
0/8 |
0/8 |
0/5 |
0/2 |
0/4 |
|
| Epidemiologist: |
0 (0%) |
0/16 |
0/10 |
0/14 |
0/9 |
0/8 |
0/8 |
0/5 |
0/2 |
0/4 |
|
| 2. |
Epidemiology Affiliation: |
||||||||||
| Yes: |
16/76 (21.0%) |
0/16 |
2/10 |
10/14 |
0/9 |
1/8 |
3/8 |
0/5 |
0/2 |
0/4 |
|
| No: |
60/76 (78.9%) |
16/16 |
8/10 |
4/14 |
9/9 |
7/8 |
5/8 |
5/5 |
2/2 |
4/4 |
|
| 3. |
Geographical Location: |
||||||||||
| North America: |
24/76 (32%) |
9/16 |
6/10 |
1/14 |
5/9 |
0/8 |
2/8 |
0/5 |
1/2 |
0/4 |
|
| Europe (includes England): |
44/76 (58%) |
7/16 |
4/10 |
10/14 |
4/9 |
8/8 |
2/8 |
4/5 |
1/2 |
4/4 |
|
| Australia or New Zealand: |
1/76 (1.%) |
0/16 |
0/10 |
1/14 |
0/9 |
0/8 |
0/8 |
0/5 |
0/2 |
0/4 |
|
| Asia: |
6/76 (8%) |
0/16 |
0/10 |
2/14 |
0/9 |
0/8 |
3/8 |
1/5 |
0/2 |
0/4 |
|
| Israel: |
1/76 (1%) |
0/16 |
0/10 |
0/14 |
0/9 |
0/8 |
1/8 |
0/5 |
0/2 |
0/4 |
|
| 4. |
Category of Intervention: |
||||||||||
| Fracture Treatment: |
70/76 (92.1%) |
16/16 |
9/10 |
12/14 |
8/9 |
7/8 |
7/8 |
5/5 |
2/2 |
4/4 |
|
| Other Treatment: |
5/76 (6.6%) |
0/16 |
1/10 |
1/14 |
1/9 |
1/8 |
1/8 |
0/5 |
0/2 |
0/4 |
|
| Vascular Treatment: |
1/76 (1.3%) |
0/16 |
0/10 |
1/14 |
0/9 |
0/8 |
0/8 |
0/5 |
0/2 |
0/4 |
|
| 5. |
Region of Body: |
||||||||||
| Upper Extremities: |
16/76 (21.0%) |
2/16 |
5/10 |
2/14 |
0/9 |
0/8 |
1/8 |
2/5 |
0/2 |
4/4 |
|
| Lower Extremity Long Bones: |
23/76 (30.3%) |
9/16 |
1/10 |
4/14 |
2/9 |
1/8 |
5/8 |
1/5 |
0/2 |
0/4 |
|
| Spine: |
2/76 (2.6%) |
0/16 |
1/10 |
0/14 |
1/9 |
0/8 |
0/8 |
0/5 |
0/2 |
0/4 |
|
| Hip: |
28/76 (36.8%) |
4/16 |
2/10 |
6/14 |
6/9 |
6/8 |
2/8 |
2/5 |
0/2 |
0/4 |
|
| Foot and Ankle |
4/76 (5.3%) |
0/16 |
1/10 |
0/14 |
0/9 |
1/8 |
0/8 |
0/5 |
2/2 |
0/4 |
|
| Knee: |
2/76 (2.6%) |
1/16 |
0/10 |
1/14 |
0/9 |
0/8 |
0/8 |
0/5 |
0/2 |
0/4 |
|
| Upper and Lower Extremity: |
1/76 (1.3%) |
0/16 |
0/10 |
1/14 |
0/9 |
0/8 |
0/8 |
0/5 |
0/2 |
0/4 |
|
| 6. |
Single or Multicentred: |
||||||||||
| Single: |
63/76 (83%) |
15/16 |
6/10 |
13/14 |
6/9 |
5/8 |
8/8 |
5/5 |
2/2 |
3/4 |
|
| Multicentred: |
13/76 (17%) |
1/16 |
4/10 |
1/14 |
3/9 |
3/8 |
0/8 |
0/5 |
0/2 |
1/4 |
|
| 7. |
Funding: |
||||||||||
| Yes: |
17/76 (22%) |
2/16 |
4/10 |
4/14 |
2/9 |
4/8 |
0/8 |
0/5 |
0/2 |
1/4 |
|
| No: |
27/76 (36%) |
10/16 |
4/10 |
10/14 |
1/9 |
0/8 |
0/8 |
1/5 |
0/2 |
1/4 |
|
| Unknown: |
32/76 (42%) |
4/16 |
2/10 |
0/14 |
6/9 |
4/8 |
8/8 |
4/5 |
2/2 |
2/4 |
|
|
* JBJS = Journal of Bone and Joint Surgery, JOT = Journal of Orthopaedic Trauma; CORR = Clinical Orthopaedics and Related Research | |||||||||||
Sung et al. BMC Musculoskeletal Disorders 2008 9:14 doi:10.1186/1471-2474-9-14 |
|||||||||||